Drug Type siRNA |
Synonyms CCT 217, CCT217 |
Target |
Action antagonists, inhibitors |
Mechanism CB1 antagonists(Cannabinoid CB1 receptor antagonists), ZNF423 inhibitors(zinc finger protein 423 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obesity | Preclinical | Canada | 10 Jan 2025 |